Phase 3 MF Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
MF
Chengdu Zenitar Biomedical Technology Co., Ltd105 enrolled2 locationsNCT07317700
Recruiting
Phase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
MyelofibrosisPrimary MyelofibrosisMF+2 more
Kartos Therapeutics, Inc.600 enrolled215 locationsNCT06479135
Recruiting
Phase 3
Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy
FMF
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT06336733
Completed
Phase 3
Dietary supplements and ocular (eye) comfort
Ocular comfort including symptoms of dry eye
Blackmores Limited80 enrolled1 locationACTRN12610000991011
Completed
Phase 2Phase 3
A randomised controlled trial of a primary care-based electronic screening and brief intervention for hazardous drinking
Harmful alcohol consumption in healthy participants
Dr Kypros Kypri572 enrolled1 locationACTRN12607000103460